Thursday, October 25, 2012

Comment to FDA about Migraines

We have from now until November 1st and not a day later to be heard. It is necessary for us to write our comments in response to the FDA request on the patient-focused drug development initiative.

The FDA is announcing a public meeting and an opportunity for public comment related to FDA's patient-focused drug development initiative. This effort provides for a more systematic approach for obtaining patient perspective on the disease severity and the currently available treatments for a set of disease areas. The FDA is publishing a preliminary list of nominated disease areas for the patient-focused drug development initiative and the criteria used for nomination. The public (that's us!) is invited to comment on this preliminary list through a public docket and at a public meeting where FDA will provide an overview of the patient-focused drug development initiative with discussion of the nominated disease areas.
(Picture taken by my son)

Migraines affect over 37 Million Americans. Peeing at night was put on the preliminary list of nominated diseases areas over Headache disorders and Migraine.  Really?!?!

Go to the FDA link to post your response. We You need you to comment.  If your response will be longer than 2000 characters, you can attach a document with your comments.

It only takes a few minutes to post your comments. It could not only change your life, but the lives of millions of other people. Here are some stats if you need them to help you make your comments.

It’s simple to get there to say your peace:
Click on this link!documentDetail;D=FDA-2012-N-0967-0001 and then go to the Comment Now! blue box in the upper right hand corner. 

We have from now until November 1st to enter our comments.

We deserve better treatments, a better quality of life and can’t let this chance pass us by.

No comments: